| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/04/2006 | WO2006047427A1 M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders |
| 05/04/2006 | WO2006047418A1 Ophthalmic compositions and methods of using the same |
| 05/04/2006 | WO2006047415A2 Factor xa compounds |
| 05/04/2006 | WO2006047392A2 Nicotinic-opioid synergy for analgesia |
| 05/04/2006 | WO2006047365A1 Pharmaceutical composition comprising diclofenac |
| 05/04/2006 | WO2006047362A2 Transdermal delivery systems |
| 05/04/2006 | WO2006047354A1 Pyrrolo [1,2-d][1,2-4]triazine as inhibitors of c-jun n terminal kinases (jnk) and p-38 kinases |
| 05/04/2006 | WO2006047322A2 A method for treatment and prevention of bacterial vaginosis |
| 05/04/2006 | WO2006047317A1 Pyrrolotriazine compounds |
| 05/04/2006 | WO2006047302A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| 05/04/2006 | WO2006047288A2 Asymmetric synthesis of dihydrobenzofuran derivatives |
| 05/04/2006 | WO2006047277A2 Inhibitors of c-fms kinase |
| 05/04/2006 | WO2006047269A2 Pharmaceutical compositions |
| 05/04/2006 | WO2006047262A1 4 [(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 05/04/2006 | WO2006047256A1 Triazoles useful as inhibitors of protein kinases |
| 05/04/2006 | WO2006047248A1 Combination of dpp-iv inhibitor, ppar antidiabetic and metformin |
| 05/04/2006 | WO2006047237A2 Heterocyclic indanone potentiators of metabotropic glutamate receptors |
| 05/04/2006 | WO2006047228A1 Asymmetric synthesis of substituted dihydrobenzofurans |
| 05/04/2006 | WO2006047196A2 Cgrp receptor antagonists |
| 05/04/2006 | WO2006047195A2 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists |
| 05/04/2006 | WO2006047172A1 Tweak receptor |
| 05/04/2006 | WO2006047162A2 Compositions and methods for treatment of disease caused by yersinia spp infection |
| 05/04/2006 | WO2006047124A1 Thienopyridines as allosteric potentiators of the m4 muscarinic receptor |
| 05/04/2006 | WO2006047080A1 Presbyopia treatment by lens alteration |
| 05/04/2006 | WO2006047032A2 Indole compounds useful as serotonin selective agents |
| 05/04/2006 | WO2006047022A1 Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis |
| 05/04/2006 | WO2006047017A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 05/04/2006 | WO2006046958A1 Decongestant and expectorant system |
| 05/04/2006 | WO2006046933A1 Sedative and spasmolytic medicinal agent and method for the production thereof (variants) |
| 05/04/2006 | WO2006046916A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006046915A1 Use of unsaturated quionoline or naphtalene derivatives as medicaments |
| 05/04/2006 | WO2006046914A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006046910A1 Novel use |
| 05/04/2006 | WO2006046880A1 Nutritional and/or pharmaceutical preparation for use in prophylaxis and treatment of disturbances in microelements absorption from the alimentary canal |
| 05/04/2006 | WO2006046847A1 Composition for the treatment of obesity and hyperlipidaemia |
| 05/04/2006 | WO2006046779A1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof |
| 05/04/2006 | WO2006046778A1 3-carbamoyl-2-pyridone derivative |
| 05/04/2006 | WO2006046774A1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
| 05/04/2006 | WO2006046746A1 Preventive/therapeutic agent for visceral pain |
| 05/04/2006 | WO2006046738A1 Process for producing indigestible dextrin containing isomerized sugar |
| 05/04/2006 | WO2006046735A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 05/04/2006 | WO2006046690A1 Composition for oral cavity |
| 05/04/2006 | WO2006046683A1 Thiazolylbenzofuran derivatives as leukotriene and prostaglandin d2 receptor antagonists |
| 05/04/2006 | WO2006046674A1 Preventive and remedy for hepatitis c virus infection |
| 05/04/2006 | WO2006046623A1 Solid medicinal preparation improved in solubility and stability and process for producing the same |
| 05/04/2006 | WO2006046593A1 Benzene compound having 2 or more substituents |
| 05/04/2006 | WO2006046575A1 Amorphous object of cinnamide compound |
| 05/04/2006 | WO2006046560A1 Propiverine-containing oral particulate preparation and process for producing the same |
| 05/04/2006 | WO2006046557A1 Abnormal protein removing composition |
| 05/04/2006 | WO2006046552A1 Novel nitrogenous heterocyclic compounds and salts thereof |
| 05/04/2006 | WO2006046528A1 Therapeutic agent for glomerular disease |
| 05/04/2006 | WO2006046527A1 Solid pharmaceutical preparation dissolved in oral cavity |
| 05/04/2006 | WO2006046492A1 Novel ppar regulating agent and method of screening the same |
| 05/04/2006 | WO2006046402A1 Triglyceride metabolism controlling agent and containing the same, food, drink, food additive and pharmaceutical |
| 05/04/2006 | WO2006046256A1 Extended release formulation of pramipexole dihydrochloride |
| 05/04/2006 | WO2006046131A1 Tetralin histamine-3 receptor antagonists |
| 05/04/2006 | WO2006046123A2 Conjugates with anti-inflammatory activity |
| 05/04/2006 | WO2006046109A1 Process for forming amorphous atorvastatin |
| 05/04/2006 | WO2006046105A1 Oxcarbazepine dosage forms |
| 05/04/2006 | WO2006046100A1 Pharmaceutical composition of alendronic acid |
| 05/04/2006 | WO2006046096A2 A polymorphic form of narwedine and its use in the synthesis of galantamine |
| 05/04/2006 | WO2006046079A1 Formulations comprising ecteinascidin and a disaccharide |
| 05/04/2006 | WO2006046071A1 Compounds and compositions useful in the treatment of neoplasia |
| 05/04/2006 | WO2006046043A1 Process for the preparation of irbesartan hydrochloride |
| 05/04/2006 | WO2006046041A1 New pharmaceutical formulations useful in the treatment of insomnia |
| 05/04/2006 | WO2006046040A1 Pharmaceutical compounds |
| 05/04/2006 | WO2006046039A2 Tetracyclic indole derivatives as antiviral agents |
| 05/04/2006 | WO2006046035A1 Pharmaceutical compounds |
| 05/04/2006 | WO2006046031A1 Pharmaceutical compounds |
| 05/04/2006 | WO2006046030A2 Tetracyclic indole derivatives as antiviral agents |
| 05/04/2006 | WO2006046024A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 05/04/2006 | WO2006046023A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 05/04/2006 | WO2006046007A1 The treatment of inflammatory bowel disease |
| 05/04/2006 | WO2006045963A2 Composition of cosmetic or pharmacological application for stimulation of synthesis of collagen |
| 05/04/2006 | WO2006045939A1 Modulating synaptic transmission by semaphorins and applications thereof |
| 05/04/2006 | WO2006045870A1 Orally-dispersible pharmaceutical compositions |
| 05/04/2006 | WO2006045865A1 Pharmaceutical formulation comprising microcapusles of statins suspended in alkyl esters of polyunsaturated fatty acids (pufa) |
| 05/04/2006 | WO2006045832A1 A new use for very low molecular weight heparins |
| 05/04/2006 | WO2006045828A1 Hiv inhibiting bicyclic pyrimidine derivatives |
| 05/04/2006 | WO2006045820A1 Pharmaceutical compositions based on nk2 antagonists for pediatric use |
| 05/04/2006 | WO2006045799A2 Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions |
| 05/04/2006 | WO2006045756A1 Use of dipyridamole in combination with antithrombotics for treatment and prevention of thromboembolic diseases |
| 05/04/2006 | WO2006045716A1 Novel diazabicyclic aryl derivatives and their medical use |
| 05/04/2006 | WO2006045640A1 Method of using adapalene in acne maintenance therapy |
| 05/04/2006 | WO2006045615A1 4- (pyrazine-2-yl) -pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors |
| 05/04/2006 | WO2006045613A1 4-methoxymethyl-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors |
| 05/04/2006 | WO2006045581A1 The use of 1, 2, 4-thiadiazolidine-3, 5-diones as ppar activators |
| 05/04/2006 | WO2006045578A2 Process for the preparation of ibandronate |
| 05/04/2006 | WO2006045565A1 Xanthine derivatives with hm74a receptor activity |
| 05/04/2006 | WO2006045564A1 Xanthine derivatives with hm74a receptor activity |
| 05/04/2006 | WO2006045554A1 (biphenyl) carboxylic acids and derivatives thereof |
| 05/04/2006 | WO2006045552A1 Purine derivatives for use as adenosin a-2a receptor agonists |
| 05/04/2006 | WO2006045541A1 Treatment and prevention of multi-drug resistance |
| 05/04/2006 | WO2006045514A1 3-arylamino pyridine derivatives |
| 05/04/2006 | WO2006045512A1 Solid pharmaceutical composition comprising donepezil hydrochloride |
| 05/04/2006 | WO2006045505A1 Mif-inhibitors |
| 05/04/2006 | WO2006045498A1 Sulfonamido compounds that antagonise the vanilloid trpv1 receptor |
| 05/04/2006 | WO2006045478A1 New indole or benzimidazole derivatives |
| 05/04/2006 | WO2006045476A2 Gpr17 modulators, method of screening and uses thereof |
| 05/04/2006 | WO2006045459A1 Thrombin inhibitors |